Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 06/09/2010
PIL Vascace Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 06/03/2009 and displayed until 06/09/2010
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 01/12/2008 and displayed until 06/03/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 26/09/2008 and displayed until 01/12/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
Updated on 29/01/2008 and displayed until 26/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 04/01/2006 and displayed until 29/01/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 16/05/2003 and displayed until 04/01/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   cilazapril